Business Wire

HCL and UpLink Call for Applications Globally for Second Challenge of Aquapreneur Innovation Initiative

21.8.2023 15:24:00 EEST | Business Wire | Press release

Share

HCL, a global conglomerate and UpLink, the open innovation platform of the World Economic Forum, announced opening the applications for the Zero Water Waste Challenge – part of the Aquapreneur Innovation Initiative. The challenge calls for innovative water usage approaches to improve freshwater conservation from supply to demand, moving towards zero water waste. At the end of the challenge, 10 winners will receive a total financial award of 1.75M CHF.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230821935081/en/

Important Dates to Note

21 August to 2 October 2023

Open for submissions

17 October to 15 November 2023

Review and selection process

January 2024

Announcement of the winning Top Innovators

This is the second challenge out of five Challenges of the HCL and UpLink’s Aquapreneur Innovation Initiative. Launched last year at Davos in May 2022, to create a first-of-its-kind innovation ecosystem for the global freshwater sector. The last date to apply for the second-year challenge is October 2nd, 2023. Full details and eligibility criteria can be found at this link. Under this initiative HCL committed $15 million until 2027 to support the water-focused entrepreneurs.

Roshni Nadar Malhotra, Chairperson, HCLTech said, As the climate change continue to intensify and fresh-water resources become scarcer, the corporates have a unique opportunity to make a substantial difference in the world we live in. At HCL, we are committed to help resolve this global crisis. In partnership with UpLink, we are all set to announce the second edition of our Aquapreneur Innovation Initiative moving towards zero water waste. While our commitment to this vital cause is unwavering, we invite fellow organizations to join us in this shared mission, contributing essential funding and catalyzing widespread exposure.”

Gim Huay Neo, Managing Director of the Centre for Nature and Climate at the World Economic Forum said, The Aquapreneur Innovation Initiative is building a vibrant innovation ecosystem for water which is crucial for the conservation and restoration of all-natural ecosystems. By connecting innovators, experts, investors and partners, this initiative is fast-tracking high-impact solutions to enhance water security. Already, we’re seeing significant impact with the ten winners of the first Innovation Challenge and we’re excited to surface and support a new cohort of aquapreneurs .”

The focus of this year’s challenge will be on:

  • Capturing and protecting freshwater supply

Protecting groundwater reservoirs by capturing additional water resources. Solutions could focus on recharging groundwater, capturing storm- and rainwater or water from the atmosphere, preventing or minimizing leakages, boosting ecosystem resilience or monitoring and managing freshwater.

  • Water re-use and recycling of materials

Increase water-efficiency by reusing and recycling water resources. Solutions could include products that enable shower, washing machine and sink water to be recycled for non-potable uses, or reuse of water in industrial facilities, cleaner and greener tech to purify reused water, etc. Ideally need to manage trade-offs, e.g. need to have sustainable energy support, as well as focus on water quality.

  • Saving water in agriculture

Reduce water withdrawal in agriculture through smart irrigation. Solutions could include precision irrigation, remote sensing, regenerative agricultural practices focused on water retention, and technologies such as mobile applications to optimize the amount and timing of water applied to crops. ​

Evaluation and selection criteria for 2nd year will include:

I. Organizational structure

  • Financially viable business model: solution demonstrates a sustainable business model and revenue approach, and presents proof of funding history, as well as investable opportunities for investors or philanthropic funders.
  • Stage: beyond the ideation phase and demonstrating the potential to scale and achieve long-term financial viability, impact, and sustainability. UpLink Top Innovators have typically reached the pilot to growth/scale phase of their operations.
  • Management team: committed, diverse and values driven management team with the right skillset and demonstrated execution capabilities, and including local staff, or the willingness to work with local stakeholders.
  • Measurement and standards verification: solution demonstrates a clear impact monitoring, evaluation, and verification framework. The metrics and indicators should be tracked transparently, reference and apply relevant, robust standards, and receive independent credentialing and third-party verification.
  • Governance and operating models: solution has a legal entity attached to the project or technology. The operating model shows the extent to which the project has achieved financial viability and sustainable revenue streams or has a vision and plan for achieving it.

II. Key characteristics:

  • Innovative: while many water technologies already exist, innovation is needed in service, pricing, partnerships, and business models.
  • Replicability: submissions from across the globe that are scalable in their local contexts and potentially replicable in different parts of the world.
  • Holistic and sustainable impact: solution demonstrates ‘win-win’ benefits for multiple agendas, particularly society and the environment. Solution supports the water agenda in the long term, delivering impact that outlasts the length of the challenge.
  • External risk: solution is aware of any risks and uncertainties associated with achieving the desired outcomes.

Top 10 water-focused entrepreneurs will be selected as Top Innovators to join the UpLink Innovation Network, an exclusive program tailored for Founders, CEOs, Executive Directors, and more. They will get various benefits, including access to selected events, projects, and communities led by the World Economic Forum and its partners. Participants will gain strategic connections with organizations within the Forum's and UpLink's networks, fostering valuable collaborations. The program extends targeted support encompassing technical, business, and operational guidance. Notably, a financial incentive is provided – among the selected Top Innovators, up to 10 can each receive 175,000 CHF from a total fund of 1.75 million CHF.

About HCL Group

Founded in 1976 as one of India’s original IT garage start-ups, HCL is a pioneer of modern computing with many firsts to its credit, including the introduction of the 8-bit microprocessor-based computer in 1978 well before its global peers. Today, the HCL enterprise has a presence across varied sectors that include technology, healthcare and talent management solutions and comprises three companies – HCL Infosystems, HCL Technologies and HCL Healthcare. The enterprise generates annual revenues of over US$12.8 billion with over 223,438 employees operating across 60 countries. For further information, visit www.hcl.com

About UpLink

UpLink is the open innovation platform of the World Economic Forum, dedicated to unlocking an ‘entrepreneur revolution’ to support positive systemic change for people and planet. Launched at the Forum’s Annual Meeting in Davos in January 2020 in collaboration with Salesforce and Deloitte, UpLink is now a thriving ecosystem of 400+ Top Innovators, investors, experts, and organizations, who are driving positive impact for the UN Sustainable Development Goals.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Dr. Pooja Arora | pooja_sikka@hcl.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release

Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release

For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye